Botanical species · safety record

Pimpinella saxifraga

The EFSA Compendium of Botanicals holds 14 constituent measurements for Pimpinella saxifraga. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Pimpinella saxifraga L.

14Constituent measurements

0Safety records

3Cited sources

7Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 7 licensed products naming Pimpinella saxifraga as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Bergapten	Roots and other underground parts	Solvent extraction	≤ 730.7 Microgram/gram	HPLC-DAD	Resolve DOI
Bergapten	Roots and other underground parts	Solvent extraction	≥ 520.68 Microgram/gram	HPLC-DAD	Resolve DOI
Isopimpinellin	Roots and other underground parts	Solvent extraction	≤ 1971.2 Microgram/gram	HPLC-DAD	Resolve DOI
Isopimpinellin	Roots and other underground parts	Solvent extraction	≥ 1416.37 Microgram/gram	HPLC-DAD	Resolve DOI
Myrcene	Fruit unspecified	Essential oil	14.1 Percent	GC-MS	Resolve DOI
Pimpinellin	Roots and other underground parts	Solvent extraction	≤ 1560.58 Microgram/gram	HPLC-DAD	Resolve DOI
Pimpinellin	Roots and other underground parts	Solvent extraction	≥ 1113.65 Microgram/gram	HPLC-DAD	Resolve DOI
Umbelliferone	Roots and other underground parts	Solvent extraction	≤ 1155.16 Microgram/gram	HPLC-DAD	Resolve DOI
Umbelliferone	Roots and other underground parts	Solvent extraction	≥ 708.48 Microgram/gram	HPLC-DAD	Resolve DOI
Xanthotoxol	Roots and other underground parts	Solvent extraction	≥ 137.99 Microgram/gram	HPLC-DAD	Resolve DOI
Xanthotoxol	Roots and other underground parts	Solvent extraction	≤ 205.44 Microgram/gram	HPLC-DAD	Resolve DOI
Genistein	Leaves	Solvent extraction	40.1 Milligram/kilogram	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Prunetin	Leaves	Solvent extraction	6.1 Milligram/kilogram	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Sissotrin	Leaves	Solvent extraction	7.2 Milligram/kilogram	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Oniszczuk, A., Waksmundzka-Hajnos, M., Podgorski, R., Nowak, R., Zukiewicz-Sobczak, W., Blicharski, T. Comparison of Matrix Solid-Phase Dispersion and Liquid-Solid Extraction Methods Followed by Solid-Phase Extraction in the Analysis of Selected Furanocoumarins from Pimpinella Roots by HPLC-DAD . Acta chromatographica, 2015, vol. 27, no. 4, p. 687-696. DOI
Abdulmanea, Khaled., Prokudina, Elena A., Lankova, Petra., Vanickova, Lucie., Koblovska, Radka., Zeleny, Vaclav., Lapcik, Oldrich. Immunochemical and HPLC identification of isoflavonoids in the Apiaceae family.. Biochemical systematics and ecology, 2012, vol. 45, p. 237-243.
Tabanca, N., Demirci, B., Ozek, T., Kirimer, N., Baser, KHC., Bedir, E., Khan, IA., Wedge, DE. Gas chromatographic-mass spectrometric analysis of essential oils from Pimpinella species gathered from Central and Northern Turkey . Journal of chromatography a, 2006, vol. 1117, no. 2, p. 194-205. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature